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Abstract
Purpose The purpose of this study is to investigate the
effect of ketorolac on biofilm formation of Staphylococcus
epidermidis isolated from patients with post-cataract
endophthalmitis.
Methods Forty S. epidermidis strains isolated from postop-
erative endophthalmitis were used for this study. Biofilms
were grown on microtitre plates for 24 h, dyed, and stained
with crystal violet. The mean optical density (OD) and the
OD ratio (ODr0OD of the treated biofilm/OD of the un-
treated biofilm) were used for quantification. The biofilms
were incubated with 13 mM ketorolac and without ketorolac
for controls.
Results The biofilm ODs of the S. epidermidis isolates un-
treated and treated with ketorolac were significantly different
(0.335±0.06 versus 0.158±0.03, respectively; mean ± SD;
P<0.001). Ketorolac reduced S. epidermidis biofilm forma-
tion by 47.6 %.
Conclusions Ketorolac, at a concentration of 13 mM, sig-
nificantly reduces the formation of biofilm by strains of S.




Endophthalmitis is a devastating sight-threatening post-
surgical ocular complication. It remains the major concern
for all cataract surgeons. Trends in favorable pre- and
perioperative prophylaxis practices are difficult to analyze
because of the infrequent occurrence of postoperative
infection.
Staphylococcus epidermidis is recognized as the most
common organism isolated in post-cataract endophthalmitis
[1]. We previously found that 75 % of our S. epidermidis
post-cataract endophthalmitis strains had the genotypic
markers of virulence (icaA, icaD, and mecA) and were
biofilm producers [2].
Nonsteroidal anti-inflammatory drugs (NSAIDs) like so-
dium salicylate decrease the production of biofilm and bac-
terial adhesion to contact lenses [3, 4]. Considering that
ketorolac is commonly used to prevent ocular inflammation,
pain, and miosis in the perioperative period of cataract
surgery, we designed an in vitro study to investigate the
effect of ketorolac on the formation of biofilm by S.
epidermidis.
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Microorganisms
The present study included 40 S. epidermidis strains
isolated from postoperative endophthalmitis between the
years 2000 and 2008. All isolates were initially identified
by classic microbiological and standard biochemical
methods. Stock cultures were kept frozen at −75 °C in
a brain heart infusion broth containing 25 % glycerol.
Two S. epidermidis reference strains were used as con-
trols: the well-known slime-producing strain ATCC
35984 (RP62A) and the non-slime-producing strain
ATCC 12228.
Table 1 Effect of ketorolac on
S. epidermidis biofilm formation
by microplate assay
Strain OD570 control (mean ± SD) OD570 (ketorolac) (mean ± SD) ODR
1 0.382±0.06 0.183±0.03 0.479
2 0.238±0.01 0.115±0.01 0.483
3 0.305±0.01 0.145±0.06 0.475
4 0.297±0.12 0.129±0.03 0.434
5 0.365±0.04 0.167±0.07 0.457
6 0.284±0.02 0.115±0.04 0.405
7 0.267±0.08 0.129±0.01 0.483
8 0.329±0.05 0.156±0.08 0.474
9 0.396±0.05 0.168±0.05 0.424
10 0.412±0.06 0.203±0.09 0.493
11 0.265±0.06 0.115±0.04 0.434
12 0.423±0.09 0.198±0.11 0.469
13 0.398±0.04 0.176±0.06 0.442
14 0.256±0.02 0.133±0.04 0.519
15 0.411±0.11 0.185±0.02 0.450
16 0.357±0.07 0.164±0.04 0.459
17 0.276±0.03 0.108±0.05 0.391
18 0.351±0.08 0.139±0.01 0.444
19 0.397±0.06 0.195±0.01 0.491
20 0.408±0.03 0.201±0.03 0.493
21 0.325±0.09 0.174±0.04 0.535
22 0.306±0.05 0.151±0.04 0.493
23 0.409±0.08 0.197±0.08 0.482
24 0.435±0.12 0.138±0.01 0.317
25 0.298±0.07 0.156±0.05 0.523
26 0.254±0.04 0.125±0.02 0.492
27 0.306±0.02 0.136±0.04 0.444
28 0.335±0.09 0.145±0.02 0.433
29 0.408±0.12 0.198±0.13 0.485
30 0.312±0.08 0.162±0.04 0.519
31 0.319±0.08 0.159±0.09 0.498
32 0.397±0.09 0.117±0.01 0.295
33 0.243±0.03 0.116±0.03 0.477
34 0.268±0.12 0.131±0.05 0.489
35 0.305±0.05 0.189±0.06 0.620
36 0.315±0.02 0.176±0.02 0.559
37 0.403±0.1 0.201±0.05 0.5
38 0.409±0.04 0.207±0.06 0.506
39 0.298±0.05 0.175±0.06 0.587
40 0.257±0.04 0.162±0.07 0.630
All strains 0.335±0.06 0.158±0.03 0.476±0.07
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Biofilms were studied using the static microtitre plate model
established by Christensen et al. [5]. Ketorolac tris salt
(Sigma) was prepared as 2-M stock solutions in PBS.
The S. epidermidis isolates were prepared as follows:
an overnight culture grown in trypticase soy broth (TSB)
at 37 °C was diluted to 1:100 in TSB. A total of 200 μl
of these cell suspensions was transferred to a sterile 96-
well polystyrene U-bottom microtitre plate in TSB alone
(control group) or in fresh TSB with 13 mM ketorolac
added (ketorolac group). The plates were incubated aer-
obically for 24 h at 37 °C. Media and planktonic cells
were removed. Adherent biofilm was fixed with 95 %
ethanol and was stained with 100 μlo f1%( w/v)c r y s t a l
violet for 5 min. Then, unbound crystal violet was re-
moved, and the wells were washed three times with
300 μl of sterile distilled water. The water was then
cleared and the microtitre plate was air-dried for 2 h.
The mean optical density (OD) was used for quantifica-
tion using a routine microtitre plate reader at a wave-
length of 570 nm. All biofilm experiments were
performed three times for each isolate to minimize the
variability in OD measurements. To measure changes in
the thickness of the biofilm, a ratio was calculated of the
biofilm OD of the isolate incubated with ketorolac
against the biofilm OD of the same isolate without
ketorolac: (ODR0OD of the treated biofilm/OD of un-
treated biofilm). The significance of differences (P<0.05)
was assessed using the Mann–Whitney U test.
Results
Biofilm ODs of the S. epidermidis isolates untreated and
treated with ketorolac were significantly different (0.335±
0.06 versus 0.158±0.03, respectively; mean ± SD; P<
0.001). Ketorolac reduced the S. epidermidis biofilm by
47.6 % or 0.476±0.07 (mean ± SD) expressed as OD ratio
(Table 1). This effect was present in the 40 clinical isolates
of S. epidermidis tested (Fig. 1).
Discussion
The incidence of post-cataract surgery endophthalmitis
varies considerably in the medical literature. An incidence
of 1.11 per 1,000 surgeries in the USA has been reported
[6], 0.48 per 1,000 surgeries in Sweeden [7], 1.4 per 1,000
surgeries in Canada [8], and 0.49 per 1,000 surgeries in
Brazil [9]. Visual outcome after endophthalmitis is generally
poor; half the patients of the Endophthalmitis Vitrectomy
Study achieved a visual acuity of 20/40 or better by 9 months
after treatment [10].
Microorganisms from the ocular and periocular surface
may enter the anterior chamber during phacoemulsification,
with reported rates of anterior chamber contamination as
high as 21 % [11]. In the Endophthalmitis Vitrectomy Study,
70 % of microbiological isolates contained coagulase-
negative micrococci [12]. The isolates involved are usually
normal flora of the surface of the eye and surrounding






































































































Fig. 1 The graph shows that
ketorolac reduced the biofilm of
all strains tested expressed as
OD ratio
J Ophthal Inflamm Infect (2012) 2:89–93 91highly virulent. S. epidermidis has been isolated from 70 %
of normal eyes [13].
Biofilm is a microbially derived sessile community
characterized by cells that are irreversibly attached to a
substratum or interface or to each other, and are embed-
ded in a matrix of extracellular polymeric substances that
they have produced exhibiting an altered phenotype with
respect to growth rate and gene transcription [14]. For-
mation of S. epidermidis biofilm is one of the most
important virulence factors. Strains isolated from septic
patients and prosthetic infections have the ica genes
which mediate biofilm formation, and the mecAg e n e
which is related to methicillin resistance. However, sap-
rophytic isolates usually do not have these markers of
virulence [15, 16].
This in vitro study shows that ketorolac reduces the
formation of biofilm by 47.6 % on all the strains tested.
The mechanism by which ketorolac decreased biofilm pro-
duction was not addressed in this study, and further research
is needed for elucidation. The concentration of ketorolac
used in our experiment is equivalent to approximately
0.5 % ketorolac, the formulation present in commercially
available products. Nonsteroidal anti-inflammatory drugs
(NSAIDs) like salicylic acid and ketorolac can prevent
adhesion and bacterial colonization of contact lenses [3].
Salicylic acid inhibited the production of teichoic acid,
slime-associated proteins, and polysaccharide/adhesin pro-
duction by S. epidermidis [17]. The adherence of bacteria to
intraocular lenses (IOLs) during implantation and coloniza-
tion of IOLs appears to have a role in the pathogenesis of
postoperative endophthalmitis [18, 19]. Herein is the impor-
tance for reducing biofilm production.
Most ophthalmic medications contain benzalkonium
chloride as preservative. It has been shown that the presence
of benzalkonium chloride at the minimal inhibitory is able to
inhibit biofilm formation. However, it was able to induce
biofilm development for the S. epidermidis at sub-MIC [20].
The failure of antibiotic treatment of biofilm-associated
infections has led to a search for additive measures to
eradicate bacteria within biofilms. Our findings support the
hypothesis that the use of ketorolac in the perioperative
period of cataract surgery may decrease the virulence of S.
epidermidis, the most common microorganism involved in
post-cataract endophthalmitis. Further studies are needed to
prove this effect in vivo.
Conclusion
Ketorolac significantly reduces the formation of biofilm by
strains of S. epidermidis that previously caused endophthal-
mitis. This effect may play a role in a new prophylactic
strategy for postoperative endophthalmitis.
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